US$ 25.03
sglt2 inhibitors and glp-1 receptor agonists together Diabetic Agents, From Metformin to GLP1 Agonists: JACC Focus Seminar GLP-1RAs and SGLT2 Inhibitors Show
Description
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML
Mol Endocrinol 1989;3:101421.ArticlePubMed 18

Tennoune, N

The European Cardiovascular Health Plan Roadmap from the European Alliance was published earlier in 2025 and calls for comprehensive approaches to incorporate the recognition of obesity as a trigger for cardiovascular disease

What was your strategy
